Apollo Endosurgery, Inc.

If you purchased Apollo Endosurgery, Inc. securities and would like to join the action, please click "Join This Action" below.

APEN STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF APOLLO ENDOSURGERY, INC. IS FAIR TO SHAREHOLDERS

November 29, 2022.

New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Apollo Endosurgery, Inc. (NASDAQ: APEN) to Boston Scientific Corporation for $10.00 per share in cash is fair to Apollo shareholders.

The investigation concerns whether Apollo and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Apollo shareholders; (2) determine whether Boston Scientific is underpaying for Apollo; and (3) disclose all material information necessary for Apollo shareholders to adequately assess and value the merger consideration. On behalf of Apollo shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Scroll to Top